Abstract Library

#4485 Inpatient admissions for hormone secretion management in patients with neuroendocrine neoplasms (NEN) treated with [177Lu]Lu-DOTA-Octreotate (LuTate) therapy over a 4.5 year period at a single high volume treatment centre

Introduction: LuTate therapy is an effective treatment for patients with somatostatin receptor expressing NEN. However, patients (pts) with functional tumours may develop an acute flare of symptoms during or after PRRT.

Conference:

Presenting Author: Kong G

Authors: Neeson L, Boehm E, Chiang C, Michael M, Sachithanandan N,

Keywords: PRRT, NET, high-risk, flare, outcomes, NEN, single centre,

#4030 Neuroendocrine tumors in pediatrics and young adults

Introduction: Neuroendocrine tumors (NETs) are rare and heterogeneous neoplasms with different origins, biology, hormone secretion, and genetic mutations. An increase in the presentation of NETs has been observed in

Conference:

Presenting Author:

Authors: González-Devia D, Andrade-Andrade P, Segovia-Gómez J, Florez-Romero A, Lopez-Panqueva R,

Keywords: Neuroendocrine Tumor, Neuroendocrine Neoplasm, Young people, Epidemiology, Neuroendocrine carcinoma,

#3310 Ectopic Cushing’s syndrome: Experience from a tertiary care center

Introduction: Neuroendocrine neoplasms (NENs) causing ectopic Cushing’s syndrome (ECS) are relatively rare and very challenging to treat.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Lase I

Authors: Lase I, Grönberg M, Strele I, Kozlovacki G, Norlën O,

Keywords: Ectopic Cushing’s syndrome, ACTH, neuroendocrine, hypercortisolism, multiple hormone secretion, bilateral adrenalectomy,

#3181 Clinical features of 8 cases of neuroendocrine tumor with multi-hormone secretion

Introduction: A group of patients with functional neuroendocrine tumors (NET) may suffer from syndrome caused by multi-hormone secretion.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Guo Y

Authors: Guo Y, Chen L, Liu M, Zhang Y, Zhang Y,

Keywords: neuroendocrine tumor, multi-hormone secretion,

#2271 Effects of Multi-Receptor Targeting Drugs in Neuroendocrine Tumors Using 3D Cell Culture

Introduction: Symptom control in functioning neuroendocrine tumors(NETs) may be difficult in some cases, thus, new therapeutic options, including multi-receptor targeting drugs are required.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Herrera-Martínez A

Authors: Herrera-Martínez A, Van Dungen R, Van Koetsveld P, Dogan-Oruc F, Culler M,

Keywords: NETs, somatostatin receptors, dopamine receptors, multi-receptor targeting drugs, hormone secretion,